A subscription to JoVE is required to view this content. Sign in or start your free trial.

In This Article

  • Summary
  • Abstract
  • Introduction
  • Protocol
  • Representative Results
  • Discussion
  • Disclosures
  • Acknowledgements
  • Materials
  • References
  • Reprints and Permissions

Summary

Here, we present a method to differentiate and expand human iPSC-derived chimeric antigen receptor (CAR)-expressing natural killer cells with improved killing against various malignancies. This protocol demonstrates the differentiation and expansion of natural killer (NK) optimized iPSC-derived CAR-NK cells and the measurement of antitumor activity against various tumor cell lines.

Abstract

Natural killer (NK) cells are innate immune cells that play a crucial role in the body's defense against tumors and viral infections. The generation of human induced pluripotent stem cell (iPSC)-derived chimeric antigen receptor (CAR) expressing NK cells has emerged as a promising avenue for "off the shelf" cancer immunotherapy. Here, we utilized an NK cell-optimized CAR construct that includes the transmembrane domain of NKG2D, the 2B4 co-stimulatory domain, and the CD3ΞΆ signaling domain, which has been demonstrated to stimulate robust antigen-specific NK cell-mediated antitumor activity. The use of iPSCs for CAR NK cell generation offers several advantages, including homogenous CAR expression, scalability, reproducibility, and the potential for clinical application. This detailed step-by-step protocol from cell engineering to differentiation enables the generation of NK cell-optimized iPSC-derived CAR-expressing NK cells, providing a standardized and targeted cancer immunotherapy with improved antitumor activity and highlighting their potential as a promising treatment option for various malignancies.

Introduction

NK cells, a type of lymphocyte within the innate immune system, are pivotal in the early defense against tumors and virally infected cells1,2,3. Unlike T cells, NK cells do not require antigen presentation via major histocompatibility complex (MHC) molecules. Instead, NK cells have a repertoire of activating and inhibitory receptors that regulate their activity3. NK cell-mediated cytotoxic activity utilizes various mechanisms, including the release of perforin and granzymes, engagement of death receptors, and the production of pro-inflammatory cytokine....

Protocol

1. Feeder-free culture method of human iPSCs

NOTE: Thaw the frozen undifferentiated human iPSCs and culture them with the use of mTeSR 1-plus on Matrigel (henceforth referred to as basement membrane matrix [BMM]) pre-coated plates, as previously described23,34. It is very important to make sure the iPSCs are not differentiated before and after engineering. Freshly thawed iPSCs should be cultured for about 2-3 passages to exhibit pluripotency morphology consistent with the human pluripotent stem cells. The following instructions are used for passaging cells from one we....

Representative Results

Schematic diagram of anti-GPC3-CAR iPSC derived NK cells differentiation and expansion
The schematic diagram illustrates the in vitro differentiation of anti-GPC3-CAR engineered NK cells derived from human induced pluripotent stem cells (iPSCs) and a schematic representation of piggyBac vector carrying GPC3 CAR construct. Initially, unmodified iPSCs are transfected with a piggyBac vector encoding the GPC3 CAR (chimeric antigen receptor). Following transfection, these GPC3 CAR-expressing iP.......

Discussion

This protocol outlines a standardized and reproducible approach for generating CAR-expressing, iPSC-derived NK cells from a consistent cell source aimed at facilitating targeted "off-the-shelf" cancer immunotherapy. Multiple preclinical and clinical studies have shown the efficacy of adoptive NK cell-based immunotherapy in treating cancers while minimizing toxicities, like graft versus host diseases (GvHD) or cytokine-release syndrome (CRS)23,42,

Disclosures

DSK is a co-founder and advisor to Shoreline Biosciences and has an equity interest in the company. DSK also consults for Therabest and RedC Bio for which he receives income and/or equity. The terms of these arrangements have been reviewed and approved by the University of California, San Diego in accordance with its conflict-of-interest policies. The remaining authors declare no competing interests.

Acknowledgements

We thank all Kaufman lab members for their support, scientific insights and discussions. These studies were supported by the NIH/NCI grants U01CA217885, P30CA023100 (administrative supplement) and the Sanford Stem Cell Institute at UCSD. JT: writing and revision of manuscript. DSK: reviewed and edited the manuscript.

....

Materials

NameCompanyCatalog NumberComments
aAPCΒ Dean A. Lee labΒ N/A
a-MEM culture mediumΒ Fisher ScientificΒ Cat#12634
APC anti-DYKDDDDK (FLAG Tag)BD BiosciencesΒ Cat#637308
APC-anti-human TRA-1-81Β ThermoFisher17-8883-42Β 
APC-CD16BD BiosciencesΒ Cat#302015
APC-CD43Β BD BiosciencesCat# 560198Β 
APC-CD45Β BD BiosciencesCat# 555485Β 
APC-GPC3BD BiosciencesΒ Cat#DB100B
APC-NKG2DΒ BD BiosciencesΒ Cat# 558071Β 
CellEvent Caspase-3/7 Green Detection ReagentΒ Thermo fisherΒ Cat#C10423
CellTrace Violet Cell Proliferation KitΒ Thermo fisherΒ Cat#C34571Cell tracing fluorescent dyeΒ 
CryoStor solutionΒ Stem Cell Technologieshttps://www.stemcell.com/products/cryostor-cs10.htmlCryopreservation medium
CTS NK XpanderGibcoA5019001
CTS NK-Xpander MediumLife TechnologiesCat#A5019001
DMEMGibco11965084
DMEM, high glucose, GlutaMAX Supplement, pyruvateGibco10569010
EasySep Human NK Cell Enrichment KitΒ StemCell Technologies, Inc.Β Cat#19055
EthanolamineSigma AldrichE9508
Fetal bovine serumΒ Fisher ScientificΒ Cat# 10437010
FITC-CD94Β BD BiosciencesΒ Cat#555888
GlutaMAX SupplementGibco35050061
GolgiPlugΒ BD BiosciencesΒ Cat#555029
GolgiStopΒ BD BiosciencesΒ Cat#554724
Ham's F-12 Nutrient Mix, GlutaMAX SupplementGibco31765035
Horse serumΒ Fisher ScientificΒ Cat#16050130
Human SerumΒ AB Sigma-AldrichCat#BP2525100
Human Stem Cell NucleofectorTM KitΒ LonzaΒ Cat# VPH-5012
Human: HePG2 cellsΒ ATCCΒ Cat#HB-8065
Human: HePG2-td-tomato-luc cellsΒ Dan S. Kaufman labN/A
Human: iPS cellsΒ Dan S. Kaufman labΒ N/A
Human: SNU-449 cellsΒ ATCCCat#CRL-2234
Human: SNU-449-td-tomato-luc cellsΒ Dan S. Kaufman labN/A
IncuCyte Caspase-3/7 Green Apoptosis AssayΒ EssenbioscienceΒ Cat#4440
L-Ascorbic acidSigma AldrichA5960
MP BiomedicalsΒ Human Serum, Type ABMP BiomedicalsICN2938249
mTeSR plusStemCell Technologies, Inc.Β 100-0276
NovoExpress softwareΒ ACEA BiosciencesΒ https://www.agilent.com/en/product/research-flow-cytometry/flow-cytometry-software/novocyte-novoexpress-software-1320805
PE/Cy7 anti-human SSEA-4 AntibodyΒ Biolegend330420
PE-CD16Β BD BiosciencesΒ Cat#560995Β 
PE-CD226BD BiosciencesΒ Cat#559789
PE-CD34Β BD BiosciencesCat# 555822Β 
PE-CD45Β BD BiosciencesΒ Cat# 555483Β 
PE-CD94Β BD BiosciencesΒ Cat#555888Β 
PE-cy7-CD56Β BioLegendCat# 318318Β 
PE-FAS LigandΒ BD BiosciencesΒ Cat#564261Β 
PE-NKp30BD BiosciencesCat# 558407
PE-NKp44Β BD BiosciencesΒ Cat#558563Β 
PE-NKp46BD BiosciencesΒ Cat#331908
PE-NKp46Β BD BiosciencesΒ Cat#557991Β 
Peripheral blood buffy coatΒ San Diego Blood Bank (https://www. sandiegobloodbank.org/)Β N/A
PE-TRAILΒ BD BiosciencesΒ Cat#565499Β 
pKT2-mCAG-IRES-GFP-ZEOΒ Branden Moriarity labΒ N/A
pMAX-GFP plasmidLonzaN/AGFP positive controlΒ 
Prism 9GraphpadΒ Version 9
pSpCas9Β GenScriptPX165
RBC Lysis Buffer (10x)BiolegendCat#420301
Recombinant human bFGF basicΒ R&D SystemsΒ Cat#4114-TC
Recombinant human BMP-4Β PeproTechCat#120-05
Recombinant human FLT-3 LigandΒ PeproTechCat# 300-19
Recombinant human IL-15Β PeproTechCat# 200-15
Recombinant human IL-2Β PeproTechCat# 200-02
Recombinant human IL-3Β PeproTechCat#200-03
Recombinant human IL-7Β PeproTechCat# 200-07
Recombinant Human Nodal ProteinR&D SystemsΒ Cat#3218-ND-025
Recombinant human SCFΒ PeproTechCat# 300-07
Recombinant Human TGF-Ξ²1PeproTechCat#100-21
Recombinant human VEGFΒ PeproTechCat# 100-20
RPMI1640Gibco11875093
Sodium seleniteSigma Aldrich214485
STEMdiff APEL 2 MediumStemCell Technologies, Inc.Β 5270EB formation medium
STEMdiff APEL2 MediumΒ StemCell Technologies, Inc.Β Cat#05270
Super piggyBac Transposase expression vectorSBICat#PB210PA-1
SYTOX AADvanced Dead Cell Stain KitThermoFisher ScientificS10274, S10349Dead cell staining solution kit
Ξ²-mercaptoethanolGibco21985023

References

Reprints and Permissions

Request permission to reuse the text or figures of this JoVE article

Request Permission

This article has been published

Video Coming Soon

JoVE Logo

Privacy

Terms of Use

Policies

Research

Education

ABOUT JoVE

Copyright Β© 2025 MyJoVE Corporation. All rights reserved